Metraipolis › archive › dc_9933433c707d

The effect of sacubitril/valsartan on urinary C-peptide excretion and endogenous insulin secretory capacity in a patient with type 2 diabetes: a case report — Europe PMC PMID:40820210

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40820210
DOI
10.1186/s40780-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-10T13:29:44.896Z
SHA-256 of the archived text
e64e92f3f1104e3064007a2aa83ebf59dee5704cd30da9723adf425229f53e62
Stable URL of this page
https://metraipolis.com/documento/dc_9933433c707d

How to cite

The effect of sacubitril/valsartan on urinary C-peptide excretion and endogenous insulin secretory capacity in a patient with type 2 diabetes: a case report — Europe PMC PMID:40820210 — Europe PMC (en), https://europepmc.org/article/MED/40820210 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9933433c707d (Metraipolis archive dc_9933433c707d, sha256 e64e92f3f1104e3064007a2aa83ebf59dee5704cd30da9723adf425229f53e62)
BibTeX
@misc{dc9933433c707d,
  title = {The effect of sacubitril/valsartan on urinary C-peptide excretion and endogenous insulin secretory capacity in a patient with type 2 diabetes: a case report — Europe PMC PMID:40820210},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40820210},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9933433c707d; sha256 e64e92f3f1104e3064007a2aa83ebf59dee5704cd30da9723adf425229f53e62},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40820210. Agents can read the archived copy with the MCP tool read_document.